Analgesics: all 2,859 studies that test it
Page 28 of 29. Open to participants first (347), then studies with results posted, then the rest; newest registration first within each.
- Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell DiseaseTerminatedNCT00252122Phase 4
- Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental ProcedureCompletedNCT00245609Phase 2
- To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence SymptomsCompletedNCT00244296Phase 4
- The Effect of Gabapentin, Ketamine and Dexamethasone on Pain and Opioid Requirements After Hip SurgeryTerminatedNCT00236223Phase 4
- Effect of Paracetamol, Pregabalin and Dexamethasone on Pain and Opioid Requirements in Patients After Hip OperationsCompletedNCT00235261Phase 4
- Duloxetine Versus Placebo in the Treatment of FMSCompletedNCT00233025Phase 3
- A Controlled Pregabalin Trial In FibromyalgiaCompletedNCT00230776Phase 3
- Intra-op Lidocaine and Ketamine Effect on Postoperative Bowel FunctionTerminatedNCT00229567Not applicable
- Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus LorazepamCompletedNCT00229125Phase 2
- Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With MorphineTerminatedNCT00224692Phase 3
- Treatment of MDEs During the Course of Psychotic Disorders With DuloxetineCompletedNCT00224302Phase 4
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple SclerosisTerminatedNCT00219908Phase 2
- Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced HyperalgesiaCompletedNCT00218374Not applicable
- A Study of Gaboxadol in Primary InsomniaCompletedNCT00209963Phase 3
- A Prospective Open-Label Extension Study of Gaboxadol in Primary InsomniaCompletedNCT00209950Phase 3
- A Prospective Active-Reference Study of Gaboxadol in Primary InsomniaCompletedNCT00209937Phase 3
- A Study of Gaboxadol in Primary InsomniaCompletedNCT00209924Phase 3
- A Study of Gaboxadol in Primary InsomniaCompletedNCT00209846Phase 3
- Effect of Paracetamol,Pregabalin and Dexamethasone on Pain and Opioid Requirements in Postoperative PatientsCompletedNCT00209495Phase 4
- Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia?CompletedNCT00206986Not applicable
- Use of Cannabinoids in Patients With Multiple SclerosisStatus unknownNCT00202423Phase 2
- Ketamine and Postoperative Analgesia in ChildrenStatus unknownNCT00200564Phase 4
- Switching to Duloxetine From Other AntidepressantsCompletedNCT00191932Phase 4
- A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and PainCompletedNCT00191919Phase 3
- Duloxetine in the Treatment of Melancholic DepressionCompletedNCT00191685Phase 3
- Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine TrialsCompletedNCT00191594Phase 3
- Open Label Phase III Duloxetine Study for Stress Urinary IncontinenceCompletedNCT00191204Phase 3
- Duloxetine in the Treatment of Stress Urinary Incontinence.CompletedNCT00191087Phase 3
- A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive DisorderCompletedNCT00191061Phase 4
- Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary IncontinenceCompletedNCT00190996Phase 3
- Safety and Effectiveness Study of Duloxetine HCl in Women of Different Backgrounds With Stress Urinary Incontinence Who May Also Have Other Various Medical Conditions.CompletedNCT00190905Phase 4
- Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia SyndromeCompletedNCT00190866Phase 3
- Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress IncontinenceCompletedNCT00190853Phase 3
- Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)CompletedNCT00190827Phase 3
- Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.CompletedNCT00190814Phase 3
- To Evaluate the Safety of Duloxetine in Patients With Stress Urinary IncontinenceCompletedNCT00190645Phase 3
- To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary IncontinenceCompletedNCT00190632Phase 3
- Efficacy and Safety of DuloxetineCompletedNCT00190619Phase 3
- Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary IncontinenceCompletedNCT00190606Phase 2
- Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress IncontinenceCompletedNCT00190567Phase 2
- Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and CognitionTerminatedNCT00189072Phase 4
- Influence of Intestinal Transporter Genetic Variants on the Bioavailability of GabapentinCompletedNCT00187707Not applicable
- Duloxetine for the Treatment of DysthymiaCompletedNCT00185575Not applicable
- Adenosine Receptors Influence Ischemia-Reperfusion InjurySuspendedNCT00184847Not applicable
- Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell LymphomaTerminatedNCT00183989Phase 2
- Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate CancerCompletedNCT00182741Phase 2
- Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's LymphomaCompletedNCT00169208Phase 2
- Gabapentin in Phantom and Stump PainCompletedNCT00169013Phase 4
- Clonidine for Neurocognitive SequelaeWithdrawnNCT00166686Phase 1/2
- The Use of Ketamine as Rescue Analgesia in the Recovery Room Following Opioid Administration. A Double-blind Randomised Trial in Postoperative PatientsCompletedNCT00163969Phase 4
- A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase AdvanceCompletedNCT00163046Phase 3
- Safety of Pregabalin in the Treatment of Pain Due to Diabetic Peripheral NeuropathyCompletedNCT00159731Phase 4
- Trial of Efficacy and Safety of Pregabalin in Subjects With Neuropathic Pain Associated With Lumbo-Sacral RadiculopathyCompletedNCT00159705Phase 3
- Pregabalin in the Treatment of Pain Due to Diabetic Peripheral NeuropathyCompletedNCT00159679Phase 4
- Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic NeuralgiaCompletedNCT00159666Phase 4
- A Study To Evaluate Pregabalin In Patients With Painful Diabetic Peripheral Neuropathy (DPN)CompletedNCT00156078Phase 4
- Study of Efficacy of Gabapentin in Therapy of Bronchial AsthmaCompletedNCT00153283Phase 4
- An Open-Label Trial of Pregabalin in Patients With FibromyalgiaCompletedNCT00151528Phase 3
- Safety and Efficacy Study of Pregabalin in FibromyalgiaCompletedNCT00151489Phase 3
- Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00151450Phase 3
- Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.CompletedNCT00150449Phase 3
- To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.CompletedNCT00150436Phase 3
- To Evaluate the Safety and Efficacy of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.CompletedNCT00150423Phase 3
- Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.CompletedNCT00150293Phase 3
- Study Evaluating Mitoxantrone in Multiple SclerosisTerminatedNCT00146159Phase 3
- Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)CompletedNCT00143975Phase 2
- Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral NeuropathyCompletedNCT00143156Phase 3
- Pregabalin Open-Label Extension Trial in Patients With Partial SeizuresCompletedNCT00143143Phase 3
- Pregabalin In Partial Seizures Extension StudyCompletedNCT00143130Phase 3
- The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3TerminatedNCT00142883Not applicable
- Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.CompletedNCT00141427Phase 4
- To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.CompletedNCT00141414Phase 2
- Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.CompletedNCT00141401Phase 3
- To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial SeizuresCompletedNCT00141388Phase 3
- To Evaluate Long-Term Safety and Efficacy of Pregabalin in the Treatment of Neuropathic Pain After Spinal Cord Injury.CompletedNCT00141375Phase 3
- Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.CompletedNCT00141362Phase 3
- To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.CompletedNCT00141336Phase 3
- Pregabalin Epilepsy Add-On TrialCompletedNCT00141258Phase 3
- To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.CompletedNCT00141245Phase 3
- Gabapentin for Carpal Tunnel SyndromeCompletedNCT00137735Phase 3
- Ketamine Versus Fentanyl as an Adjunct to Propofol-Assisted Emergency Department Procedural SedationCompletedNCT00137085Not applicable
- The Addition of Clonidine to 0.2% Ropivacaine for Wound Instillation After Minor Lower Abdominal Surgery in ChildrenCompletedNCT00130091Phase 2
- Effect of Ketalar to Prevent Postoperative Chronic Pain After MastectomyStatus unknownNCT00129597Phase 4
- A Study of Duloxetine in the Treatment of FibromyalgiaCompletedNCT00125892Phase 3
- Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety DisorderCompletedNCT00122863Phase 3
- A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122850Phase 3
- A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety DisorderCompletedNCT00122837Phase 3
- Duloxetine Compared With Placebo in Patients With Generalized Anxiety DisorderCompletedNCT00122824Phase 3
- Ketamine Sedation in Mechanically Ventilated PatientsStatus unknownNCT00122759Not applicable
- Chemotherapy Followed by Zevalin for Relapsed Mantle Cell LymphomaCompletedNCT00119730Phase 2
- Magnesium Sulfate Versus Indomethacin for Preterm LaborTerminatedNCT00116623Phase 4
- Gabapentin for the Treatment of Hot Flashes in Menopausal WomenCompletedNCT00112138Phase 3
- An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)CompletedNCT00103818Phase 3
- Study of MK0928 in Healthy Adult Volunteers in a Model of Insomnia (0928-006)(COMPLETED)CompletedNCT00102167Phase 3
- Safety of MK0928 on Insomnia in the Elderly (0928-005)(COMPLETED)CompletedNCT00095043Phase 3
- Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)CompletedNCT00094627Phase 3
- A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 YearsCompletedNCT00079105Phase 2
- Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With DepressionCompletedNCT00073411Phase 3
- Duloxetine vs. Active Comparator in the Treatment of Patients With DepressionCompletedNCT00071695Phase 4